Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2026-01-11 @ 2:22 PM
Study NCT ID:
NCT02500550
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2015-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
Sponsor:
Kiadis Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR-AIR-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None